CERVICAL PRECANCER IN TERMS OF PERSISTENT HUMAN PAPILLOMAVIRUS INFECTION
Main Article Content
Abstract
The aim of the research – to determine the features of cervical intraepithelial neoplasia (CIN) with persistent human papillomavirus infection.
Materials and methods. This prospective study included 63 patients with CIN associated with HPV. Assessment of persistence of HPV was based on detection of HPV when retesting 12 months. Depending on the results allocated to 2 groups: 1A group (main, n = 26), including patients with CIN after treatment and persistence of HPV 32,0 years (26,25-39,00); 1B group (comparison, n = 37) – patients with CIN without HPV persistence after treatment 31,0 years (26,0-35,0).
Results. In the beginning of the study two or more types of HPV HR was prevalent in patients of 1A group and were detected in 34.6 % of cases, against 16.2 % of cases among patients 1B group (p < 0.05). Two groups were dominated by HPV 16 (p > 0.05). After 12 months of treatment was 3.5-fold predominance of patients with mono-infection on HPV compared to co-infection of HPV (p < 0.05). Among patients with HPV-associated precancer recurrence with CIN II-III and absence of regression in CIN I were observed in 6 patients, made up 9.52 %, exclusively in 1A group, while in 1B group there was no recurrence (f = 3,92; p < 0.01).
Conclusion. The features of the original infection status in patients with CIN on the background of persistent HPV infection. The recurrence of the disease in CIN II-III and the lack of regression of CIN I is marked when persistent for HPV infection that indicate risk of recurrence of cervical precancer after treatment in the absence of elimination of HPV.
Downloads
Article Details
Issue
Section
References
The international Agency for research on cancer. http://globocan.iarc.fr/old/FactSheets/cancers/cervix-new.asp
Kaprin AD, Starinsky VV, Petrova GV, Gretsova OP, Aleksandrova LM. Malignant neoplasms of female genital organs in Russia: situation and problems. V.F.Snegirev Archives of Obstetrics and Gynecology. 2014; 1(2): 44-47. (Каприн А.Д., Старинский В.В., Петрова Г.В., Грецова О.П., Александрова Л.М. Злокачественные новообразования женских половых органов в России: ситуация и проблемы //Архив акушерства и гинекологии им. В.Ф. Снегирева. 2014. Т. 1, № 2. С. 44-47)
Klinyshkova TV, Turchaninov DV, Samosudova BI. Epidemiological aspects of cervical precancer in the female population of Omsk (according to the data of a randomized study). Russian Bulletin of Obstetrician-gynecologist. 2013; 13(4): 13-17. (Клинышкова Т.В., Турчанинов Д.В., Самосудова И.Б. Эпидемиологические аспекты цервикального предрака у женского населения г. Омска (по материалам выборочного исследования) //Российский вестник акушера-гинеколога. 2013. Т.13, № 4. С. 13-17)
Prilepskaya VN., Nazarova NM. Sulamanidze LA., Burmenskaya OV., Trofimov DYu, Pavlovich SV. Anogenital diseases associated with HPV infection. Gynecology. 2015; 17(1): 4-7. (Прилепская В.Н., Назарова Н.М., Суламанидзе Л.А., Бурменская О.В., Трофимов Д.Ю., Павлович С.В. Заболевания аногенитальной области, ассоциированные с папилломавирусной инфекцией //Гинекология. 2015. Т. 17, № 1. С. 4-7)
Klinyshkova TV, Samosudova IB. Correlation of colposcopic indices with Р16INK4 КI-67, and Е7 expression in patients with cervical intraepithelial neoplasia. Obstetrics and gynecology. 2013; 3: 80-84. (Клинышкова Т.В., Самосудова И.Б. Взаимосвязь кольпоскопических индексов с экспрессией Р16INK4, М-67, Е7 у больных цервикальной интраэпителиальной неоплазией //Акушерство и гинекология. 2013. № 3. С. 80-84)
Mariani L, Sandri MT, Preti M, Origoni M et al. HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions. J Cancer. 2016 Jan 1; 7(1): 107-114
Pirtea L, Grigoraş D, Matusz P et al. Age and HPV type as risk factors for HPV persistence after loop excision in patients with high grade cervical lesions: an observational study. BMC Surg. 2016 Oct 6; 16(1): 70
Klinyshkova TV, Samosudova BI, Turchaninov DV. Results of treatment of patients with cervical intraepithelial neoplasms of high severity associated with human papillomavirus. Gynecology. 2012; 14(4): 23-26. (Клинышкова Т.В., Самосудова И.Б., Турчанинов Д.В. Результаты лечения больных с цервикальными интраэпителиальными неоплазиями высокой степени тяжести, ассоциированными с вирусом папилломы человека //Гинекология. 2012. Т. 14, № 4. С. 23-26)
De Vivar AD, Dawlett M, Wang JP et al. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring. Arch Pathol Lab Med. 2015 Feb; 139(2): 219-224.
Skinner SR, Wheeler CM, Romanowski B. Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. Int J Cancer. 2016 May 15; 138(10): 2428-2438
Chang Y, Duan Y. Analysis of factors associated with recurrence of cervical intraepithelial neoplasia after loop electrosurgical excision procedure. Zhonghua Yi Xue Za Zhi. 2014 Dec; 94(47): 3751-3754
Rodriguez-Manfredi A, Alonso I, del Pino M et al. Predictors of absence of cervical intraepithelial neoplasia in the conization specimen. Gynecol Oncol. 2013 Feb; 128(2): 271-276
Vriend HJ, Bogaards JA, van Bergen JE et al. Incidence and persistence of carcinogenic genital humanpapillomavirus infections in young women with or without Chlamydia trachomatis co-infection. Cancer Med. 2015 Oct; 4(10): 1589-1598